Sutton, United Kingdom

Leo Leung

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Sutton, GB (2020 - 2023)
  • Manchester, GB (2022 - 2024)
  • Macclesfield, GB (2024)

Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations of Leo Leung in Cancer Treatment

Introduction

Leo Leung is a prominent inventor based in Sutton, GB, known for his significant contributions to the field of cancer research. With a total of six patents to his name, he has focused on developing innovative compounds that target specific biological processes involved in cancer progression.

Latest Patents

One of Leo Leung's latest patents involves lysyl oxidase inhibitors. This invention relates to compounds that are useful as inhibitors of the lysyl oxidase (LOX) and lysyl oxidase-like (LOXL) family members. These compounds are particularly relevant in the treatment of conditions mediated by LOX and LOXL, such as cancer. The invention also includes the identification of biomarkers that predict responsiveness to a LOX inhibitor, which could enhance treatment efficacy. Another notable patent features hexahydropyrrolo[3,4-c]pyrrole derivatives, which are pharmacologically effective as LOX inhibitors. These compounds are believed to be useful in treating various cancers.

Career Highlights

Leo Leung is affiliated with the Institute of Cancer Research, Royal Cancer Hospital, where he continues to advance his research and innovations. His work has the potential to significantly impact cancer treatment strategies and improve patient outcomes.

Collaborations

Leo collaborates with esteemed colleagues, including Caroline Joy Springer and Dan Niculescu-Duvaz, to further enhance the scope and application of his research.

Conclusion

Leo Leung's innovative work in developing lysyl oxidase inhibitors and other compounds showcases his commitment to advancing cancer treatment. His contributions are paving the way for new therapeutic options in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…